YARDLEY, PA — Managed Markets Insight & Technology (MMIT) recenlty announced the winners of the quarterly Patient Access Awards to honor manufacturers who are committed to improving patient access to life-saving therapies.
“There is so much innovation happening in the pharmaceutical industry today,” said Diane Watson, CEO of MMIT, a Norstella company. “We are thrilled to recognize the manufacturers who not only bring innovative drugs to market but also ensure that patients can access them.”
In this research, payer and physician stakeholders assess and rank the performance of manufacturers across a series of factors, including the manufacturer’s overall commitment to a disease, account representative support, patient and family support programs and resources, patient copay assistance, physician education and support, and HUB services.
“Congratulations to each of the winners, all of whom are dedicated to developing life-saving drugs and making sure they get into the hands of the patients who need them,” said Watson. “We are honored to recognize your efforts.”
The winners of the Q3 Patient Access Awards are:
Biologics & Injectables:
- Janssen (Crohn’s Disease)
- ViiV Healthcare (HIV)
- Jazz Pharmaceuticals (Narcolepsy)
- Janssen (Ulcerative Colitis)
Learn more information about the Patient Access Awards here.
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.